Beijing Qifu Ruicao Medical Technology

Beijing Qifu Ruicao Medical Technology is a biotechnology company specializing in the research, development, and production of high-purity rare ginsenosides. Founded in 2016 and based in Beijing, the company utilizes proprietary enzymatic and chemical transformation technologies to produce rare ginsenosides such as Rh2, Rg3, and aPPD. These compounds are being developed for their anti-tumor, anti-inflammatory, and immune-modulating properties, with a primary focus on oncology and supportive care. Qifu Ruicao's business model integrates natural product extraction with the development of pharmaceutical compositions and health supplements, aiming to modernize Traditional Chinese Medicine. The company's platform enables the large-scale production of rare ginsenosides that are typically found in minute quantities in nature, providing a consistent supply for clinical research and commercial applications.